| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
|
Pessoa de Magalhães Filho, Roberto José
|
|
2019
|
19 |
1 |
p. e43-e50
|
artikel
|
| 2 |
A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma
|
Ailawadhi, Sikander
|
|
2019
|
19 |
1 |
p. 29-34
|
artikel
|
| 3 |
Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
|
Smith, Brianna N.
|
|
2019
|
19 |
1 |
p. 1-8
|
artikel
|
| 4 |
Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment
|
Frerichs, Kristine A.
|
|
2019
|
19 |
1 |
p. e9-e11
|
artikel
|
| 5 |
Editorial Board
|
|
|
2019
|
19 |
1 |
p. A4-A5
|
artikel
|
| 6 |
Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM
|
Gavriatopoulou, Maria
|
|
2019
|
19 |
1 |
p. 23-28
|
artikel
|
| 7 |
Elotuzumab in Combination with Lenalidomide and Dexamethasone for Treatment-resistant Immunoglobulin Light Chain Amyloidosis With Multiple Myeloma
|
Iqbal, Shumaila Muhammad
|
|
2019
|
19 |
1 |
p. e33-e36
|
artikel
|
| 8 |
Factors Affecting Early Death and Survival of Patients With Acute Promyelocytic Leukemia Treated With ATRA-Based Therapy Regimens
|
Sun, Jianai
|
|
2019
|
19 |
1 |
p. e63-e70
|
artikel
|
| 9 |
Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France
|
Despiégel, Nicolas
|
|
2019
|
19 |
1 |
p. e13-e28
|
artikel
|
| 10 |
Hemophagocytic Lymphohistiocytosis in a Patient With Multiple Myeloma
|
Hsu, Caroline M.
|
|
2019
|
19 |
1 |
p. e29-e32
|
artikel
|
| 11 |
Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature
|
Farris, Michael
|
|
2019
|
19 |
1 |
p. e1-e8
|
artikel
|
| 12 |
Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy
|
Yoder, Alison K.
|
|
2019
|
19 |
1 |
p. e51-e61
|
artikel
|
| 13 |
Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience
|
Williams, AnnaLynn M.
|
|
2019
|
19 |
1 |
p. 41-47
|
artikel
|
| 14 |
Influence of Blood Count, Cardiovascular Risks, Inherited Thrombophilia, and JAK2 V617F Burden Allele on Type of Thrombosis in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms
|
Horvat, Ivana
|
|
2019
|
19 |
1 |
p. 53-63
|
artikel
|
| 15 |
Interim Functional Imaging Is an Independent Predictor of Progression-free Survival in Advanced Classical Hodgkin Lymphoma – A Real-world Analysis
|
Damlaj, Moussab
|
|
2019
|
19 |
1 |
p. e71-e79
|
artikel
|
| 16 |
Management of Polycythemia Vera: A Survey of Canadian Physician Practice Patterns
|
Habib, Laura Anne
|
|
2019
|
19 |
1 |
p. e37-e42
|
artikel
|
| 17 |
Modified VR-CAP, Alternating With Rituximab and High-dose Cytarabine: An Effective Pre-transplant Induction Regimen for Mantle Cell Lymphoma
|
Smith, Stephen D.
|
|
2019
|
19 |
1 |
p. 48-52
|
artikel
|
| 18 |
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP)
|
Gaudio, Francesco
|
|
2019
|
19 |
1 |
p. 35-40
|
artikel
|
| 19 |
Role of Proteasome Inhibitors in Relapsed and/or Refractory Multiple Myeloma
|
Leleu, Xavier
|
|
2019
|
19 |
1 |
p. 9-22
|
artikel
|
| 20 |
Table of Contents
|
|
|
2019
|
19 |
1 |
p. A6-A7, A12-A13
|
artikel
|
Tijdschrift beschrijving